EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months

Mengxue Yan, Siping Li, Jingyi Lu, Zhichun Liu, Leixi Xue iD

Lupus · 2026-12 · 35 (14) · 1472-1478

DOI: 10.1177/09612033261481990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lupus, online erschienen am 24.08.2026. Verfasst von Mengxue Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit nennt 24 Literaturangaben. Gefördert von: the Gusu Health Talent Plan of Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to explore the clinical characteristics of patients with late-onset systemic lupus erythematosus (SLE) during the initial stage of disease onset and to evaluate disease activity.

Method

Data from patients with SLE whose disease onset was ≤3 months were retrospectively collected, and the patients were classified into the late- and early-onset SLE groups based on an age cutoff of 50 years.

Results

This study included 145 patients, including 31 with late-onset SLE and 114 with early-onset SLE. Compared with the early-onset SLE group, the late-onset SLE group had a lower prevalence of rash (25.8% vs. 45.6%, p = 0.040) and anti-dsDNA antibody positivity (54.8% vs. 72.5%, p = 0.027), whereas pericarditis was more frequent (29.0% vs. 12.3%, p = 0.047) and the C3 levels were higher (0.640 [0.400, 0.892] g/L vs. 0.460 [0.324, 0.701] g/L, p = 0.018). As regards disease activity, the SLEDAI 2000 was 10 (8, 20) in the late-onset SLE group and 15 (10, 22) in the early-onset SLE group ( p = 0.066), whereas the SLE-DAS was similar between the groups (13.33 [11.50, 28.45] vs 15.48 [8.56, 25.18], p = 0.744). More than half of patients with late-onset SLE received high-dose or intravenous pulse corticosteroid therapy, with no statistically significant difference compared with patients with early-onset SLE.

Conclusions

Patients with very early-stage late-onset SLE exhibited distinct clinical and serological features. However, their disease activity was essentially consistent with that of early-onset SLE, and they often require intensive immunosuppressive therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansFemaleAge of OnsetMaleRetrospective StudiesAdultMiddle AgedComplement C3Antibodies, AntinuclearSeverity of Illness IndexPericarditisExanthemaImmunosuppressive AgentsTime Factors

Stichwörter der Autor:innen

clinical characteristicsdisease activitylate onsetsystemic lupus erythematosus

Substanzen

Complement C3Antibodies, Antinuclearanti-dsDNA autoantibodyImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China.

ORCID-Profile: Leixi Xue

Förderung

  • the Gusu Health Talent Plan of Suzhou

Zitieren

APA

Yan, M., Li, S., Lu, J., Liu, Z., & Xue, L. (2026). Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months. Lupus, 35(14), 1472-1478. https://doi.org/10.1177/09612033261481990

Vancouver

Yan M, Li S, Lu J, Liu Z, Xue L. Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months. Lupus. 2026;35(14):1472-1478. doi:10.1177/09612033261481990

BibTeX
@article{Yan2026,
  author = {Yan, Mengxue and Li, Siping and Lu, Jingyi and Liu, Zhichun and Xue, Leixi},
  title = {Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months},
  journal = {Lupus},
  year = {2026},
  volume = {35},
  number = {14},
  pages = {1472--1478},
  doi = {10.1177/09612033261481990}
}
Kostenlos starten →